Lupus
OMNI CRS filled quotas for a rare indication Lupus trial, delivering over 1,500 pre-screened patients in just 4 months with high down-funnel conversions.
The Results
- 1,500+ prescreened referrals delivered
- Strict criteria met for rare Lupus indication
- Patient quotas filled within 4 months
- Exceptional down-funnel conversions achieved
“OMNI CRS has been a great partner for us over the years. Their lead quality has been excellent which improves our down funnel metrics. They’ve been especially valuable helping us find niche cohorts for our more challenging studies.”
-Affiliate and Partnerships Manager
The Challenge & OMNI CRS’ Approach
The Challenge
The client struggled to hit quotas for a rare Lupus study with tight inclusion/exclusion criteria. Internal recruitment methods proved ineffective, threatening timelines.
OMNI CRS' Approach
- Amplifying CRO’s existing channels , OMNI retargeted demographic and patient profile parameters
- Set a strategy based on strict inclusion/exclusion criteria for a rare disease
- Created high-intent referral generation for rare patient cohorts
Why It Worked
By layering targeted strategies with a network of proven affiliates, OMNI CRS efficiently reached rare patient populations and ensured timely, cost-effective enrollment with superior conversion rates.